CJC-1295 + Ipamorelin (10mg / 20mg) — Research Peptide

CJC-1295 + Ipamorelin (CAS 863288-34-0 / 170851-70-4) is a synthetic research peptide supplied by Eclipse Peptides as a high-purity reference compound for in-vitro laboratory study. It is characterized by the molecular formula Blend (CJC-1295: C152H252N44O42 / Ipamorelin: C38H49N9O5) and a molecular weight of CJC-1295: 3367.9 g/mol · Ipamorelin: 711.85 g/mol, provided as a white lyophilized powder at a minimum purity of >99%.

CJC-1295 + Ipamorelin is studied in the context of growth factor research and remains an active area of scientific investigation. Eclipse supplies CJC-1295 + Ipamorelin strictly as a reference material for research applications. Each batch is third-party tested and ships with a Certificate of Analysis. Store lyophilized at 2–8°C.

This product is for in-vitro research use only. It is not a drug, supplement, or medical product and is not intended for human or animal consumption.

A blend of CJC-1295 (a synthetic GHRH analog, no-DAC) and Ipamorelin (a synthetic pentapeptide). Both remain active areas of scientific research and investigation.

CJC-1295 and Ipamorelin have been investigated in preclinical research exploring GHRH and ghrelin receptor pathways.

A batch-specific Certificate of Analysis is included with every shipment of this compound. Historical batch COAs are available from our documentation hub.